SVA [SINOVAC BIOTECH] 6-K: DOJ Closes Investigation of Sinovac About Sinovac www.sinovacbio.com

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-09-17
Original SEC Filing: Click here


Webplus: SVA/20180917/6-K/2_EX-99.1/000.htm SEC Original: tv502950_ex99-1.htm
DOJ Closes Investigation of Sinovac About Sinovac www.sinovacbio.com Sinovac Biotech Ltd. is a China-based biopharmaceutical Company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac’s product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), and mumps. Healive,




Webplus: SVA/20180917/6-K/1/000.htm SEC Original: tv502950_6k.htm



Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-09-17CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200

Home Page Forums

By | 2018-09-17T12:01:27+00:00 September 17th, 2018|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar